[Glycosaminoglycans in diabetic nephropathy].
This review refers to the nephro-protective role of glycosaminoglycans, especially in diabetic nephropathy.
Olszowska
A
A
Z Kliniki Nefrologii ze Stacja Dializ Centralnego Szpitala Klinicznego WAM.
D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism; D003928:Diabetic Nephropathies / Q000378:metabolism* / Q000517:prevention & control; D018450:Disease Progression; D006025:Glycosaminoglycans / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D007678:Kidney Glomerulus / Q000187:drug effects / Q000378:metabolism; D011507:Proteinuria / Q000517:prevention & control
D006025:Glycosaminoglycans